Eric M. Gershwin

5.4k total citations · 1 hit paper
37 papers, 3.9k citations indexed

About

Eric M. Gershwin is a scholar working on Hepatology, Epidemiology and Immunology. According to data from OpenAlex, Eric M. Gershwin has authored 37 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hepatology, 23 papers in Epidemiology and 11 papers in Immunology. Recurrent topics in Eric M. Gershwin's work include Liver Diseases and Immunity (31 papers), Liver Disease Diagnosis and Treatment (21 papers) and Liver physiology and pathology (7 papers). Eric M. Gershwin is often cited by papers focused on Liver Diseases and Immunity (31 papers), Liver Disease Diagnosis and Treatment (21 papers) and Liver physiology and pathology (7 papers). Eric M. Gershwin collaborates with scholars based in United States, Australia and Japan. Eric M. Gershwin's co-authors include Ross L. Coppel, Keith D. Lindor, Marshall Kaplan, Jenny Heathcote, Nora V. Bergasa, Raoul Poupon, Aftab A. Ansari, Howard J. Worman, Ellen B. Gold and Carlo Selmi and has published in prestigious journals such as Hepatology and Journal of Autoimmunity.

In The Last Decade

Eric M. Gershwin

37 papers receiving 3.8k citations

Hit Papers

Primary biliary cirrhosis # † 2009 2026 2014 2020 2009 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Primary biliary cirrhosis # †
    2009 809 citations Keith D. Lindor, Eric M. Gershwin et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric M. Gershwin United States 30 3.2k 2.5k 1.2k 645 554 37 3.9k
Marshall Kaplan United States 19 1.5k 0.5× 1.2k 0.5× 707 0.6× 369 0.6× 277 0.5× 33 2.1k
F. Cassani Italy 36 2.4k 0.7× 2.2k 0.9× 682 0.6× 181 0.3× 881 1.6× 72 3.0k
George N. Dalekos Greece 23 2.0k 0.6× 1.8k 0.7× 709 0.6× 159 0.2× 526 0.9× 43 2.5k
H. Lobeck Germany 28 1.7k 0.5× 1.3k 0.5× 1.4k 1.2× 156 0.2× 158 0.3× 146 3.7k
Kohsaku Sakaguchi Japan 27 1.3k 0.4× 1.1k 0.4× 697 0.6× 452 0.7× 98 0.2× 92 2.5k
Kalliopi Zachou Greece 35 2.8k 0.9× 2.7k 1.1× 518 0.4× 143 0.2× 567 1.0× 109 3.3k
Riccardo Volpes Italy 30 1.9k 0.6× 1.5k 0.6× 808 0.7× 254 0.4× 118 0.2× 90 2.8k
Tobias Heintges Germany 28 3.3k 1.0× 2.9k 1.2× 265 0.2× 163 0.3× 213 0.4× 93 4.5k
Daniela Zauli Italy 26 1.1k 0.3× 1.0k 0.4× 292 0.2× 175 0.3× 456 0.8× 63 1.8k
Luisa Garcı́a-Buey Spain 24 1.4k 0.4× 1.3k 0.5× 188 0.2× 235 0.4× 278 0.5× 70 2.3k

Countries citing papers authored by Eric M. Gershwin

Since Specialization
Citations

This map shows the geographic impact of Eric M. Gershwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric M. Gershwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric M. Gershwin more than expected).

Fields of papers citing papers by Eric M. Gershwin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric M. Gershwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric M. Gershwin. The network helps show where Eric M. Gershwin may publish in the future.

Co-authorship network of co-authors of Eric M. Gershwin

This figure shows the co-authorship network connecting the top 25 collaborators of Eric M. Gershwin. A scholar is included among the top collaborators of Eric M. Gershwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric M. Gershwin. Eric M. Gershwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lleò, Ana, Weici Zhang, W. Hayes McDonald, et al.. (2014). Shotgun proteomics: Identification of unique protein profiles of apoptotic bodies from biliary epithelial cells. Hepatology. 60(4). 1314–1323. 63 indexed citations
2.
Tsuda, Masanobu, Weici Zhang, Guoxiang Yang, et al.. (2012). Deletion of Interleukin (IL)-12p35 Induces Liver Fibrosis in Dominant-Negative TGFβ Receptor Type II Mice. Hepatology. 57(2). 806–816. 73 indexed citations
3.
Lindor, Keith D., Eric M. Gershwin, Raoul Poupon, et al.. (2009). Primary biliary cirrhosis # †. Hepatology. 50(1). 291–308. 809 indexed citations breakdown →
4.
Zhang, Weici, Rahul Sharma, Xiaosong He, et al.. (2008). Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis #. Hepatology. 49(2). 545–552. 77 indexed citations
5.
Chuang, Ya‐Hui, Yuki Moritoki, Ruth Y. Lan, et al.. (2008). Adoptive transfer of CD8+ T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice. Hepatology. 47(6). 1974–1982. 90 indexed citations
6.
Oertelt‐Prigione, Sabine, Roman Rieger, Carlo Selmi, et al.. (2007). A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis. Hepatology. 45(3). 659–665. 117 indexed citations
7.
Moritoki, Yuki, Zhe‐Xiong Lian, Heike Wulff, et al.. (2007). AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers. Hepatology. 45(2). 314–322. 67 indexed citations
8.
Kamihira, Takashi, Shinji Shimoda, Minoru Nakamura, et al.. (2005). Biliary epithelial cells regulate autoreactive T cells: Implications for biliary-specific diseases. Hepatology. 41(1). 151–159. 47 indexed citations
9.
Matsumura, Shuji, Judy Van de Water, Hiroto Kita, et al.. (2002). Contribution to antimitochondrial antibody production: Cleavage of pyruvate dehydrogenase complex-E2 by apoptosis-related proteases. Hepatology. 35(1). 14–22. 41 indexed citations
10.
Miyakawa, Hiroshi, Atsushi Tanaka, Kentaro Kikuchi, et al.. (2001). Detection of Antimitochondrial Autoantibodies in Immunofluorescent Ama–Negative Patients With Primary Biliary Cirrhosis Using Recombinant Autoantigens. Hepatology. 34(2). 243–248. 155 indexed citations
11.
12.
Leung, Patrick S.C., Gordon D. Benson, Jorge Findor, et al.. (2000). Mucosal Immunity and Primary Biliary Cirrhosis: Presence of Antimitochondrial Antibodies in Urine. Hepatology. 32(5). 910–915. 60 indexed citations
13.
Katayanagi, Kazuyoshi, Judy Van de Water, Thomas P. Kenny, et al.. (1999). Generation of Monoclonal Antibodies to Murine Bile Duct Epithelial Cells: Identification of Annexin V As A New Marker of Small Intrahepatic Bile Ducts. Hepatology. 29(4). 1019–1025. 15 indexed citations
14.
Coppel, Ross L., et al.. (1999). The immunobiology of bile and biliary epithelium. Hepatology. 30(2). 351–357. 90 indexed citations
15.
Harada, Kenichi, Yoshiko Sudo, Naoko Kono, et al.. (1999). In situ nucleic acid detection of PDC-E2, BCOADC-E2, OGDC-E2, PDC-E1α, BCOADC-E1α, OGDC-E1,and the E3 binding protein (protein X) in primary biliary cirrhosis. Hepatology. 30(1). 36–45. 15 indexed citations
16.
Leung, Patrick S.C., Takashi Iwayama, Ross L. Coppel, & Eric M. Gershwin. (1990). Site-directed mutagenesis of lysine within the immunodominant autoepitope of PDC-E2. Hepatology. 12(6). 1321–1328. 48 indexed citations
17.
Coppel, Ross L., Thomas Prindiville, David R. Fregeau, et al.. (1990). The Relative Affinity of Recombinant Dihydrolipoamide Transacetylase for Autoantibodies in Primary Biliary Cirrhosis. Hepatology. 11(5). 717–722. 11 indexed citations
18.
Fregeau, David R., Thomas Prindiville, Ross L. Coppel, et al.. (1990). Inhibition of α–Ketoglutarate Dehydrogenase Activity by A Distinct Population of Autoantibodies Recognizing Dihydrolipoamide Succinyltransferase in Primary Biliary Cirrhosis. Hepatology. 11(6). 975–981. 58 indexed citations
19.
20.
Surh, Charles D., Anne Cooper, Ross L. Coppel, et al.. (1988). The predominance of IgG3 and IgM isotype antimitochondrial autoantibodies against recombinant fused mitochondrial polypeptide in patients with primary biliary cirrhosis. Hepatology. 8(2). 290–295. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marshall Kaplan Breakdown of academic impact, for papers by F. Cassani Breakdown of academic impact, for papers by George N. Dalekos Breakdown of academic impact, for papers by H. Lobeck Breakdown of academic impact, for papers by Kohsaku Sakaguchi Breakdown of academic impact, for papers by Kalliopi Zachou Breakdown of academic impact, for papers by Riccardo Volpes Breakdown of academic impact, for papers by Tobias Heintges Breakdown of academic impact, for papers by Daniela Zauli Breakdown of academic impact, for papers by Luisa Garcı́a-Buey
Rankless by CCL
2026